ATE114478T1 - Verfahren zur kontrolle der leukozyten- extravasation. - Google Patents

Verfahren zur kontrolle der leukozyten- extravasation.

Info

Publication number
ATE114478T1
ATE114478T1 AT88307397T AT88307397T ATE114478T1 AT E114478 T1 ATE114478 T1 AT E114478T1 AT 88307397 T AT88307397 T AT 88307397T AT 88307397 T AT88307397 T AT 88307397T AT E114478 T1 ATE114478 T1 AT E114478T1
Authority
AT
Austria
Prior art keywords
leukocyte
specific
cell surface
extravasation
synovial
Prior art date
Application number
AT88307397T
Other languages
English (en)
Inventor
Eugene C Butcher
Sirpa T Jalkanen
Original Assignee
Univ Leland Stanford Junior
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Leland Stanford Junior filed Critical Univ Leland Stanford Junior
Application granted granted Critical
Publication of ATE114478T1 publication Critical patent/ATE114478T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2884—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against CD44
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • External Artificial Organs (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT88307397T 1987-08-11 1988-08-10 Verfahren zur kontrolle der leukozyten- extravasation. ATE114478T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8447887A 1987-08-11 1987-08-11
US8449087A 1987-08-11 1987-08-11

Publications (1)

Publication Number Publication Date
ATE114478T1 true ATE114478T1 (de) 1994-12-15

Family

ID=26771020

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88307397T ATE114478T1 (de) 1987-08-11 1988-08-10 Verfahren zur kontrolle der leukozyten- extravasation.

Country Status (5)

Country Link
EP (1) EP0303463B1 (de)
JP (1) JPH02196A (de)
AT (1) ATE114478T1 (de)
CA (1) CA1340202C (de)
DE (1) DE3852236T2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0462111A4 (en) * 1988-12-23 1992-07-08 The Board Of Trustees Of The Leland Stanford Junior University Homing sequences and their uses
DE4134982A1 (de) * 1991-10-23 1993-04-29 Kernforschungsz Karlsruhe Verwendung von antikoerper enthaltenden praeparationen zur immunsuppression
US6551593B1 (en) 1995-02-10 2003-04-22 Millennium Pharmaceuticals, Inc. Treatment of Inflammatory bowel disease by inhibiting binding and/or signalling through α 4 β 7 and its ligands and madcam
US7750137B2 (en) 1995-09-01 2010-07-06 Millennium Pharmaceuticals, Inc. Mucosal vascular addressins
US7803904B2 (en) 1995-09-01 2010-09-28 Millennium Pharmaceuticals, Inc. Mucosal vascular addressing and uses thereof
US7147851B1 (en) 1996-08-15 2006-12-12 Millennium Pharmaceuticals, Inc. Humanized immunoglobulin reactive with α4β7 integrin
US10040855B2 (en) 2011-05-02 2018-08-07 Millennium Pharmaceuticals, Inc. Formulation for anti-α4β7 antibody
UA116189C2 (uk) 2011-05-02 2018-02-26 Мілленніум Фармасьютікалз, Інк. КОМПОЗИЦІЯ АНТИ-α4β7 АНТИТІЛА

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3110610A1 (de) * 1981-03-18 1982-10-28 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen Chemokinesine und chemotaxine der leukozyten und des entzuendungsgewebes: natuerliche mediatoren zur selektiven reversiblen motilitaetsbeinflussung (chemokinesis) und chemische anlockung (chemotaxis) bei der ansammlung von leukozyten

Also Published As

Publication number Publication date
DE3852236T2 (de) 1995-04-06
EP0303463A3 (en) 1990-04-04
JPH02196A (ja) 1990-01-05
EP0303463A2 (de) 1989-02-15
DE3852236D1 (de) 1995-01-12
EP0303463B1 (de) 1994-11-30
CA1340202C (en) 1998-12-15

Similar Documents

Publication Publication Date Title
FI101381B1 (fi) Nukleotidisekvenssi ja menetelmä polypeptidin HSA(1-387) tuottamiseksi
ATE88097T1 (de) Verfahren und system zur entfernung von immunosuppressiven bestandteilen aus saeugetierblut.
DE3588254D1 (de) Gag-Antigen und dessen Verwendung zum Nachweis von LAV-Infektion, sowie in immunogenen Zusammensetzungen
DE19975064I2 (de) Tumornekrosefaktor, Verfahren zu seiner Herstellung, denselben enthaltende Zusammensetzungen, daf}r kodierende DNS und diese DNS verwendendes Testverfahren.
ATE153696T1 (de) Verfahren und desoxyribonukleinsäure zur herstellung von gewebefaktor-protein
DE69727595D1 (de) Verfahren zur herstellung eines extraktes des plättchenwachstumsfaktors für zubereitungen zur wundheilung
EP0767657A4 (de) Neues verfahren zur herstellung von bekannten und neuen 2'-modifizierten nukleosiden durch intramolekulare nukleophile substitution
DE69102401D1 (de) Verfahren zur Herstellung von kappa-Casein-Glycomakropeptid.
ATE83252T1 (de) Verfahren zur herstellung kolloidaler suspensionen von organopolysiloxanen.
ATE110265T1 (de) Verwendung von sigma-rezeptor-liganden zur herstellung eines anxiolytikums.
ATE78483T1 (de) Verfahren zur herstellung von methacryloxyoder acryloxyorganosilanen oder -organosiliconen.
ATE68826T1 (de) Verfahren zur herstellung von reifem, menschlichem serum-albumin.
ATE114478T1 (de) Verfahren zur kontrolle der leukozyten- extravasation.
DE69311183D1 (de) Verfahren zur Herstellung von Acryloxy- oder Methacryloxygruppen enthaltenden Organosiliconen
PT817851E (pt) Dna codificador do virus do papiloma humano tipo 18
DE69319012D1 (de) Protein mit Knochenbildungs-Eigenschaften und Verfahren zu seiner Herstellung
DE3884644D1 (de) Verfahren zur Herstellung von 5'-Inosinsäure.
DE69735583D1 (de) Semisynthetisches verfahren zur herstellung von didemninanalogen
DE3880194D1 (de) Zyklisches antikoagulierendes peptid.
DE69025100D1 (de) Verfahren zur Herstellung von Polycarbonaten mit kontrolliertem Molekulargewicht aus Bischloroformiaten
DE59004119D1 (de) Verfahren zur Herstellung von Pigmenten auf Isoindolbasis.
DE3881467D1 (de) Vasokonstriktor-peptid.
ATE212056T1 (de) Methoden zur herstellung von rna viren aus cdna
DE69529750D1 (de) Verbesserungen in der herstellung von proteinen in wirtszellen
DE69019052D1 (de) Verfahren zur Herstellung von 2'Deoxy-5-trifluoromethyl-ss-uridin.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties